Lead Sponsor

Pfizer

Age

18 - 74 years

Sex

ALL

Healthy Volunteers

No

•Male or non-pregnant, non-breastfeeding female, 18 to 74 years of age at Visit 1
•Body Mass Index ≥30.0 kg/m2 at Visit 1, with stable body weight, defined as \<5 kg change in the 12 weeks before Visit 1
•Eligible and willing to receive required background medicine
•Willing and able to comply with all study procedures

•Any medical or psychiatric condition or laboratory abnormality, or recent serious illness or hospitalization, that may increase the risk of study participation or, in the investigator's judgment, make the participant inappropriate for the study including diagnosis of type 2 diabetes mellitus, type 1 or secondary forms of diabetes.
•Use of any prohibited prior or concomitant medication(s)
•Presence of specified abnormalities on diagnostic assessments including clinical laboratory tests at Visit 1.

Related studies

NCT06894498 · Obesity and Obesity-related Medical Conditions, Weight Loss

NCT05124808 · Gestational Diabetes, Pregnancy, High Risk, and more

NCT06937086 · Ulcerative Colitis, Obesity or Overweight

NCT07595549 · Obesity, Overweight and/or Obesity, and more

NCT07282340 · Childhood Obesity

A Study to Learn About the Study Medicine Called PF-07976016 in Adults With Obesity